Archives
-
o2h Ventures Announces Seed Investment in AscendBio, A Company Advancing Therapies for Metabolic and Respiratory Diseases
03 May, 2024
-
o2h Ventures Invests in Vesynta, a Company Developing an AI Software to Maximise Therapeutic Potential and De-risk drug development
23 April, 2024
-
o2h Ventures invests in ClotProtect, a Company Developing Treatment to Improve Bleeding and Survival Outcomes
22 April, 2024
-
o2h Ventures Invests in Stratosvir – Advancing Viral Immunotherapy For Late-Stage Cancer
17 April, 2024
-
o2h Ventures Announces SEIS Investment in Innovative mRNA-Based Hearing Loss Treatment Company, CamGene Therapeutics
05 April, 2024
-
Pioneering innovation in biotech investments via o2h Ventures’ human health S/EIS funds
20 February, 2024
-
Fuelling academic innovation and fostering entrepreneurship
08 January, 2024
-
o2h Ventures – Embracing autumn with exciting updates and amazing achievements!
12 October, 2023
-
o2h Ventures continues to back Pencil Biosciences in its £5.6M Seed investment
29 September, 2023
invest in the growth potential of UK life science & AI